Molecular Evidence of Human Fasciolosis Due to Fasciola gigantica in Iran: A Case Report
Abstract
Fascioliasis is a foodborne zoonotic disease caused by the two parasite species Fasciola hepatica and F. gigantica. In spite of the presence of both species of Fasciola in the livestock, to our knowledge, to date, no cases of human F. gigantica infection have been reported in Iran officially. Here, we report such a case in a 25 yr old woman referred to The Department of Medical Parasitology and Mycology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran in 2016. CT imaging and MRCP revealed an ill-defined lesion of segments of liver. Specific ELISA produced a positive result besides detecting egg of the parasite via stool exam. The identification of parasite species was performed by the DNA extracted from the eggs and sequencing ITS-1, in addition to comparison to GenBank retrieved sequences, using the BLAST search tool. The sample showed 100% identity with F. gigantica. She was treated for fasciolosis with a single dose of Egaten® 10 mg/kg with positive response. This is the first case of human fasciolosis due to F. gigantica reported in Iran.
Rokni MB. Helminth-Trematode: Fasciola hepatica and F. gigantica. In: Motarjemi Y, editor. Encyclopedia of Food Safety. 1st ed. Amsterdam: Else-vier/Academic Press; 2015. p. 140-5.
Mas-Coma S, Valero MA, Bargues MD (2009). Fasciola, lymnaeids and human fascioliasis, with a global overview on disease transmission, epidemiology, evolutionary genetics, molecular epidemiology and control. Adv Parasitol, 69:41-146.
Aryaeipour M, Rouhani S, Bandehpour M et al (2014). Genotyping and phylogenetic analysis of Fasciola spp. Isolated from sheep and cattle using PCR-RFLP in Ardabil province, Northwestern Iran. Iran J Public Health, 43(10): 1364–1371.
Cwiklinski K, O'Neill SM, Donnelly S et al (2016). A prospective view of animal and human Fasciolosis. Parasite Immunol, 38(9):558-68.
Ashrafi K (2015). The status of human and animal Fascioliasis in Iran: A narrative review article. Iran J Parasitol, 10(3): 306-28.
Salahi-Moghaddam A, Arfaa F (2013). Epidemiology of human fascioliasis outbreaks in Iran. J Arch Mil Med, 1(1):6-12.
Heydarian P, Ashrafi K, Mohebali M et al (2017). Seroprevalence of human fasciolosis in Lorestan Province, western Iran, in 2015–16. Iran J Parasitol, 12(3): 389–397.
Rokni MB, Massoud J, O’Neill SM et al (2002). Diagnosis of human fasciolosis in the Gilan Province of Northern Iran: application of cathepsin L-ELISA. Diagn Microbiol Infect Dis, 44(2):175-9.
Bozorgomid A, Nazari N, Rahimi H et al (2016). Molecular Characterization of Animal Fasciola spp. Isolates from Kermanshah, Western Iran. Iran J Public Health, 45(10):1315-1321
Tamura K, Stecher G, Peterson D et al (2013). MEGA6: molecular evolutionary genetics analysis version 6.0. Mol Biol Evol, 30(12):2725-9.
Rojas CAA, Jex AR, Gasser RB et al (2014). Techniques for the diagnosis of Fasciola infections in animals: room for improvement. Adv Parasitol, 85:65-107.
Mansour W, Kaddah M, Shaker Z et al (1998). A monoclonal antibody diagnoses active Fasciola infection in humans. J Egypt Soc Parasitol, 28(3):711-27.
Aksoy D, Kerimoglu U, Oto A et al (2005). Infection with Fasciola hepatica. Clin Microbiol Infect, 11(11):859-61.
Şamdanci E, Şahin N, Dağli AF et al (2017). Fascioliasis: a rare parasitic infection-mimicking tumor in the liver: report of two cases. Turk Patoloji Derg, 1(1):001-3.
Zali MR, Ghaziani T, Shahraz S et al (2004). Liver, spleen, pancreas and kidney involvement by human fascioliasis: imaging findings. BMC Gastroenterol, 4(1):15.
Ashrafi K, Massoud J, Holakouei K et al (2004). Evidence suggesting that Fasciola gigantica might be the most prevalent causal agent of fascioliasis in Northern Iran. Iran J Public Health, 33(4):31-7.
| Files | ||
| Issue | Vol 47 No 5 (2018) | |
| Section | Case Report(s) | |
| Keywords | ||
| Fasciola gigantica PCR ELISA Diagnosis Iran | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
